

Afren: Canaccord Genuity reinstates with a target price of 120p and a hold recommendation. Bodycote: N+1 Singer cuts target price from 850p to 835p, ...


AIM-listed drug developer Summit, which develops therapies for Duchenne Muscular Dystrophy and C. difficile infection, on Wednesday said its chief exe...


Antofagasta: Westhouse Securities downgrades from add to neutral with a target price of 885p. Investec places its target price (prev.: 690p) under rev...


Abderdeen Asset Management: Berenberg cuts target price from 530p to 510p and maintains a buy recommendation. African Barrick Gold: Numis takes targe...


African Barrick Gold: UBS ups target price from 260p to 290p and maintains a buy recommendation. Deutsche Bank cuts target price from 300p to 280p and...